Levy Michael J, Norton Ian D, Clain Jonathan E, Enders Felicity B, Gleeson Ferga, Limburg Paul J, Nelson Heidi, Rajan Elizabeth, Topazian Mark D, Wang Kenneth K, Wiersema Maurits J, Wilson Walter R
Division of Gastroenterology and Hepatology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA.
Clin Gastroenterol Hepatol. 2007 Jun;5(6):684-9. doi: 10.1016/j.cgh.2007.02.029.
BACKGROUND & AIMS: Recent studies showed that endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) is a low-risk procedure for causing bacteremia and infectious complications when sampling solid lesions of the upper gastrointestinal (GI) tract. As a result, antibiotics are not recommended for prophylaxis against endocarditis. Our aim was to prospectively evaluate the risk of bacteremia and other infectious complications in patients undergoing EUS FNA of lower GI tract lesions.
Patients referred for EUS FNA of lower GI tract lesions were considered for enrollment. Patients were excluded if there was an indication for preprocedure antibiotic administration based on American Society for Gastrointestinal Endoscopy guidelines, had taken antibiotics within the prior 7 days, or if they had a cystic lesion. Blood cultures were obtained immediately before the procedure, after flexible sigmoidoscopy/radial EUS, and 15 minutes after EUS FNA.
One hundred patients underwent a total of 471 FNAs (mean, 4.7 FNAs/patient; range, 1-10 FNAs/patient). Blood cultures were positive in 6 patients. Cultures from 4 patients (4.0%, 95% confidence interval, 1.6%-9.8%) grew coagulase-negative Staphylococcus (n = 2), Peptostreptococcus stomatis (n = 1), or Moraxella (n = 1), which were considered contaminants. Two patients (2.0%, 95% confidence interval, 0.6%-7%) developed bacteremia: Bacteroides fragilis (n = 1) and Gemella morbillorum (n = 1). No signs or symptoms of infection developed in any patient.
EUS FNA of solid lesions in the lower GI tract should be considered a low-risk procedure for infectious complications that does not warrant prophylactic administration of antibiotics for the prevention of bacterial endocarditis.
近期研究表明,内镜超声(EUS)引导下细针穿刺抽吸(FNA)在对上消化道(GI)实体病变进行采样时,引发菌血症和感染性并发症的风险较低。因此,不建议使用抗生素预防心内膜炎。我们的目的是前瞻性评估接受EUS-FNA检查下消化道病变患者发生菌血症和其他感染性并发症的风险。
考虑纳入因下消化道病变接受EUS-FNA检查的患者。如果根据美国胃肠内镜学会指南有术前使用抗生素的指征、在过去7天内使用过抗生素或有囊性病变,则将患者排除。在操作前、乙状结肠镜检查/径向EUS后以及EUS-FNA后15分钟立即采集血培养样本。
100例患者共进行了471次FNA(平均每位患者4.7次FNA;范围为每位患者1-10次FNA)。6例患者血培养呈阳性。4例患者(4.0%,95%置信区间为1.6%-9.8%)的培养物中生长出凝固酶阴性葡萄球菌(n = 2)、口腔消化链球菌(n = 1)或莫拉菌属(n = 1),这些被视为污染物。2例患者(2.0%,95%置信区间为0.6%-7%)发生菌血症:脆弱拟杆菌(n = 1)和麻疹孪生球菌(n = 1)。所有患者均未出现感染的体征或症状。
下消化道实体病变的EUS-FNA应被视为感染性并发症风险较低的操作,无需预防性使用抗生素来预防细菌性心内膜炎。